For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230526:nRSZ7253Aa&default-theme=true
RNS Number : 7253A Majedie Investments PLC 26 May 2023
Majedie Investments PLC
Half-Year Financial Report
31 March 2023
Majedie Investments plc ("Majedie" or the "Company") is pleased to present its
Half-Year Financial Report for the six months ended 31 March 2023.
The Half-Year Financial Report can be found on the Company's website at
https://www.majedieinvestments.com/reporting
(https://www.majedieinvestments.com/reporting) or by contacting the Company
Secretary on telephone number 07936 332 503.
Financial Highlights
Half Year ended
31 March 2023
Total shareholder return (including dividends): 32.6%
Net asset value (NAV) total return (debt at par including dividends): 13.9%
NAV total return (debt at fair value including dividends): 13.8%
NAV per share (debt at par value): 245.0p
NAV per share (debt at fair value): 244.2p
Revenue Return per share: 0.7p
Quarterly Dividend: 1.8p
Total assets*: £150.6m
* Total assets are defined as total assets less current liabilities.
Chief Executive's Report
In the six months ended 31 March 2023 the NAV at par and the NAV at fair value
(net asset value with debt at par and fair value) rose by 13.9% and 13.8%
respectively on a total return basis. Total shareholder return (including
dividends) increased by 32.6%.
The Company announced a change to its Investment Management Arrangements in
November 2022 and held a General Meeting on 25 January 2023 at which
shareholders approved the appointment of Marylebone Partners LLP (Marylebone)
and a change in its Investment Policy. Subsequent to the meeting, Marylebone
took over the management of the Company's portfolio and by 31 March it had
been largely transitioned to the new investment policy.
Since the announcement of the appointment of Marylebone, it is encouraging
that the discount to NAV of the Company has narrowed, especially as many
peers' discounts have widened. The Board also notes the higher turnover in the
Company's shares and that several new investors have joined the share
register.
Results and Dividends
The Company had a capital gain for the six months to 31 March 2023 of £15.8m.
Total income from investments fell to £1.2m compared to £2.0m in the six
months to 31 March 2022 largely due to the absence of a dividend from Majedie
Asset Management following its sale to Liontrust PLC (Liontrust) on 30 March
2022.
Total administrative expenses and management fees were £1.2m compared to
£0.8m for the six months to 31 March 2022. The increase is due to fees
incurred in the change in Investment Management Arrangements, in particular
fees payable to JP Morgan Cazenove, as corporate broker, and Dickson Minto
LLP, as legal advisor. Marylebone has agreed to waive half of the investment
management fees payable by the Company for a period of twelve months from
their appointment as investment manager, this will be amortised over two and a
half years as shown in note 3 in the full Half-Year Financial Report. The
Company also paid performance fees to Liontrust of £0.7m which relate to its
holding, now sold, in the Tortoise Fund.
Following the approval of the changes to the investment objective and policy
the Company will pay quarterly dividends which are expected to comprise
approximately 0.75% of the relevant quarter end NAV, leading to an aggregate
annual dividend target of approximately 3%. Accordingly, in relation to the
quarter ended 31 March 2023 a quarterly dividend of 1.8p was declared on 5 May
2023 which will be paid on 2 June 2023 to shareholders on the register on 19
May 2023.
As a consequence of the new arrangements the Company will no longer be
self-managed and Marylebone will become the AIFM in due course. The Company
will no longer have an office or any employees.
Performance
The overall performance for the Company was strong as equity markets recovered
during the period. The large allocation that the Company had in the UK equity
market was beneficial as was the continued strong performance of the Tortoise
Fund. The UK Equity Segregated Portfolio was sold on 25 January 2023 and the
Global Equity Fund, International Equity Fund and the Tortoise Fund were all
sold on 22 February 2023 to enable the Company's assets to remain invested
during the transition.
The share price of Liontrust increased by 43% in the six months to 31 March
2023, though the price remains 50% below the level received as consideration
by the Company as part of the sale of Majedie Asset Management (MAM). The
performance targets (to be met by MAM by 31 March 2023) which would have
triggered a deferred benefit from Liontrust to the Company were not achieved,
therefore the deferred payment benefit has lapsed. The Company had attributed
no value to this contingent payment in its NAV. The Company has continued to
reduce its holding in Liontrust, selling 216,000 shares for a consideration of
£2.3m over the six months to 31 March 2023.
Performance of Liontrust Funds until their sale
30 September to sale date Since MI invested
% % % % % %
Fund Benchmark Relative performance Fund Benchmark Relative performance
return return return return
UK Equity Segregated 15.4 13.9 1.5 38.9 60.9 (22.0)
Fund to 25 January 2023
Global Equity Fund to 22 February 2023 7.8 6.5 1.3 156.9 144.9 12.0
International Equity Fund to 22 February 2023 10.0 10.4 (0.4) 27.6 16.1 11.5
Tortoise Fund to 18.0 - - 48.7 - -
22 February 2023
MAM/Liontrust 6 months 42.8 - - (49.6) - -
to 31 March 2023
NAV Bridge 30 September 2022 to 25 January 2023 (date of Fund Manager change)
NAV 30.09.22 £116.9m
UK Equity Segregated Portfolio £9.3m
Tortoise Fund £4.6m
Global Equity Fund £3.4m
International Equity Fund £1.6m
Liontrust £0.5m
Cash (£2.2m)
Debenture (£0.8m)
Other Net Assets (£1.2m)
NAV 25.01.23 £132.9m
Transition to the New Investment Policy
Under the recently adopted Investment Objective and Policy, the Company will
target annualised total returns (net of fees and expenses, in GBP) of at least
4% above the UK Consumer Price Index, measured over rolling five year periods.
Marylebone, the Company's investment manager will invest in three
differentiated investment strategies, in order to achieve the Board's key
objectives of improving performance, reducing the Company's discount to NAV
and developing the Company's culture;
1. Special Investments
2. External Managers
3. Direct Investments
Following approval of the new objective and policy the portfolio has been
transitioned so that all Liontrust Funds were sold. Marylebone have
re-invested the proceeds in both External Managers and Direct Investments and
made initial investments into Special Investments. It is anticipated that this
will be fully transitioned by the end of the calendar year as suitable
investments are sourced.
The investments that feature in the new 'Liquid Endowment' Strategy offer not
only a clearly differentiated portfolio, but also (and importantly) a
portfolio that is marked to market regularly. This is possible either because
the underlying assets are both liquid and traded on recognised markets, or the
idea sponsor has a policy which usually entails asking an independent third
party to price the investment on a regular basis. The only asset in the
portfolio as at the date of this interim report that requires a Director's
valuation is the 7.5% holding in the Marylebone Partnership LLP. This is
currently valued at £5,000 (see Note 12 in the full Half-Year Financial
Report). One Special Investment is Tier 3 (see Note 9 in the full Half-Year
Financial Report) and is currently valued at £2.2m.
Under the new investment policy, the portfolio has a more significant exposure
to non-sterling
assets, predominantly USD, which exposes the shareholders to currency risk and
therefore the manager has a currency hedge in place, as permitted under the
Company's investment policy. The portfolio is hedged monthly using forward
contracts and covers the currency exposure within External Managers and Direct
Investments. Special Investments are not hedged because they are less liquid.
The Current Portfolio
Allocation of Total Assets at 31 March 2023
Value % of Total
£000s
Assets
External Managers 72,339 48.0%
Direct Investments 29,932 19.9%
Special Investments 9,510 6.3%
Liontrust 3,297 2.2%
Net Cash/Other Assets/Realisation Fund* 35,532 23.6%
Total Assets 150,610 100.0
* £12.2m had been allocated to External Managers and settled on 1 April 2023.
Special Investments
The portfolio holds 6.3% of total assets in Special Investments that are
sourced through Marylebone's proprietary network. These comprise two
'stressed' credit opportunities and two activist co-investments in public
equities (one in a niche Software business and the other in a Consumer
Discretionary business) and a commodity investment. The final Special
Investment is completely uncorrelated to markets and pursues a strategy
similar to factoring, overseen by a manager in the US with whom Marylebone has
a fifteen-year relationship.
External Managers
At 31 March 2023 the portfolio held 48.0% in fourteen External Managers with a
further £12.2m allocated to External Managers awaiting settlement. Marylebone
regards all of these managers as pre-eminent in their respective specialist
areas. By 'role in portfolio' profile, equity centric funds comprise 53% of
the total External Manager allocation and is invested with specialists in mid
cap software, turnarounds, value-based activist situations, biotech,
Scandinavian, other European and Chinese equities.
To complement these equity funds, Marylebone has allocated to four credit
funds with a focus on 'performing yet stressed' opportunities in the US,
Europe and emerging markets, this comprises 32% of External Managers.
Marylebone's chosen managers have targeted situations that are short duration,
where risk is mitigated by positioning at the top of the company's capital
structure. Having navigated at least four previous cycles, the Marylebone team
consider stressed/distressed credit an area of true differentiation for the
Company's portfolio.
The final allocation to External Managers, which comprises 15%, is to managers
that offer exposure to commodities, (in particular uranium and copper) as well
as to the broader theme of energy transition from fossil fuels to clean
energy.
Direct Investments
Direct Investments in public equities comprises 19.9% of total assets. After
the dislocations of the previous eighteen months Marylebone has built a
focussed portfolio of equities that have not only met their quality criteria,
but have also satisfied their strict research and selection process. This part
of the Company's portfolio has divergent return drivers and is not determined
by style or specific macroeconomic outcomes. As a general observation,
Marylebone believes that earnings estimates for developed markets do not
appear to fully reflect the possibility of an economic slowdown and the
portfolio therefore, has modest exposure to sectors such as Property, Energy
and Financials where expectations are high and is overweight. Industrials and
IT where expectations are more realistic.
Largest ten holdings in each Strategy
Special % External Managers % Direct Investments %
Investments
Project Bungalow 2.0 Perseverance DXF Value Fund 4.3 Alight Inc 1.8
Project Uranium 1.5 Silver Point Capital Offshore 4.3 KBR Inc 1.7
Project Retain 1.4 Eicos Fund SA 4.1 Pernod Ricard SA 1.7
Project Saint 1.2 KL Event Driven UCITS Fund 4.0 Laboratory Corp 1.6
Project Challenger 1.0 Keel Capital SA SICAV-SIF Longhorn 3.8 Weir Group 1.6
Project Care 0.7 Millstreet Credit Offshore 3.7 Wabtec Corp 1.5
Praesidium Strategic Software Opportunities 3.7 Howmet Aerospace Inc 1.4
Energy Dynamics 3.4 Sage Group PLC 1.3
Paradigm BioCapital Partners 3.3 UnitedHealth Group Inc 1.2
CastleKnight Offshore 3.2 Adobe Inc 1.1
The 7.5% stake in Marylebone Partners LLP is currently valued at cost as in
note 12 in the full Half-Year Financial Report.
At the end of the period the Company held larger than normal levels of net
cash and other
assets, a significant proportion of which was subsequently deployed in early
April into External Managers and Special Investments.
Following the change in investment policy and the transition to the 'Liquid
Endowment' strategy the Company will no longer publish daily NAVs. Instead, an
estimate of the month end will be published around the tenth day of the month.
A mid-month NAV will be published around the twenty fifth day of each month
accompanied by the final NAV for the prior month. Importantly the prices are
almost all generated from observed marked to market prices with the exception
of the 7.5% stake in Marylebone Partners LLP and Project Retain. The
proportion of the portfolio that is marked to markets accounts for over 98% of
the assets.
Outlook
The consequences of Central Bank tightening in 2022 are becoming apparent
especially in the US Regional Bank sector evidenced by the collapse of Silicon
Valley Bank and the subsequent failure of Signature and First Republic. The
ensuing crisis of confidence across the sector led to the acquisition of
Credit Suisse by UBS. Whilst prices have largely recovered after the initial
shock as the largest banks are well capitalised, markets remain nervous. One
of the consequences could be Central Banks adopting a less hawkish stance on
further tightening as the availability of credit has become scarcer. Inflation
remains stubborn, but adjustment to commodity price increases and fuel prices
caused by the invasion of Ukraine by Russia over a year ago, tight money
supply and improvements in the global supply chain as China opens up should
lead to lower inflation in the second half of the year. Geo-political risks
remain at heightened levels and increase uncertainty. Against such a
background the Company's portfolio which now combines idiosyncratic equity
return with targeted positioning in External Managers together with specialist
credit and real assets should provide downside protection as well as
benefiting from increased sources of returns.
Sir William Barlow Bt.
Chief Executive
For and on behalf of the Board
25 May 2023
Further Information
A copy of the Half-Year Financial Report will be submitted shortly to the
National Storage Mechanism ("NSM") and will be available for inspection at the
NSM, which is situated
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) , in accordance with
DTR 6.3.5(1A) of the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.
ENQUIRIES
If you have any enquiries regarding this announcement, please contact Mr
William Barlow on 020 7382 8185.
END
Neither the contents of the Company's website nor the contents of any website
accessible from hyperlinks on this announcement (or any other website) is
incorporated into, or forms part of, this announcement.
LEI: 2138007QEY9DYONC2723
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR NKPBNABKDDPB